Professional Documents
Culture Documents
Hypercholesterolemia Homozygous
Familial / Monogenic
Heterozygous
Acquired
Hypertriglyceridaemia Chylomicronemia
Hereditary
Hyperlipidemia
Familial
Hypertriglyceridemia
Familial dysbeta-
lipoproteinemia
Mixed
Polygenic Hyperapobeta-
lipoproteinemia
GENERAL OVERVIEW:
HYPERTRIGLYCERIDEMIA
Endrocrine Disorders
Pregnancy and
Hormones
Acquired
Mixed Chylomicronemia
Hereditary
Familial
Hypertriglyceridemia
CLASSIFICATION
BASED ON LIPIDS
FREDRICKSON CLASSIFICATION OF
HYPERLIPOPROTEINEMIA
Average of
Elevated Serum Serum
Type overnight Associated clinical disorders
particles TC TG
serum
Creamy top,
Chylomicrons,
V turbid Diabetes + ++
VLDL
bottom
HYPERCHOLESTEROLEMIA
Familial Hypercholesterolemia due to
1. LDL receptor defect
2. Defective Apo B100
3. Increased function of PCSK9
Polygenic
Hypercholesterolemia
Familial / Monogenic
Hyperlipidemia Acquired
Hypertriglyceridaemia
Hereditary
Mixed
It is a
FAMILIAL HYPERCHOLESTEROLEMIA disorder of
lipoprotein,
INTRODUCTION NOT LIPIDS.
FH is the most common autosomal dominant genetic disease. The clinical syndrome
(phenotype) is characterized by extremely elevated levels of low density
lipoprotein cholesterol (LDL-C) and a propensity to early onset atherosclerotic
cardiovascular disease. Homozygotes generally manifest disease in childhood.
DYSLIPOPROTEINEMIA
It is a more preferred term over dyslipidemia because dyslipidemia
basically means a disorder in any form of the lipid metabolism, whilst
dyslipoproteinemia concerns more on the lipoprotein.
There are more than 1600 different mutations in the LDLR gene. The mutations
at the LDLR locus have been categorized into four classes of alleles based on the
phenotypic behavior of the mutant protein:
Class I Null, in which synthesis is defective.
Class II Transport defective, in which intracellular transport from the
endoplasmic reticulum to Golgi is impaired.
Class III Binding defective, in which proteins are synthesized and
transported to the cell surface normally, but binding of LDL is defective.
Class IV Internalization defective, in which proteins reach the cell surface
and bind LDL normally but the receptors do not cluster in the coated pits,
thereby minimizing LDL internalization.
FAMILIAL HYPERCHOLESTEROLEMIA
MUTATIONS IN PCSK9 GENE
PCSK9 is a serine protease that is secreted by the liver into the plasma that
binds to an extracellular domain of the LDLR (principally) on liver cells. This
binding prevents LDL receptors from recycling to the cell surface and
ultimately accelerates their destruction inside liver cells.
The net effect is that the clearance of LDL is reduced and plasma
levels increase by two- to threefold.
FAMILIAL HYPERCHOLESTEROLEMIA
DIAGNOSIS (1)
and either
Polygenic
Hypercholesterolemia
Familial / Monogenic
Hyperlipidemia Acquired
Hypertriglyceridaemia
Hereditary
Mixed
POLYGENIC HYPERCHOLESTEROLEMIA
We can only differentiate this from the familial type via genetic
testing. Similar to patients with monogenic FH, these patients have
familial aggregation of moderate hypercholesterolemia and the
premature onset of coronary heart disease (CHD).
Poorly understood but multiple abnormalities in LDL metabolism are
likely involved.
These abnormalities in LDL metabolism include mild defects in the LDL
receptor, defective apo B-100, increased synthesis of apo B, and the
presence of the apo E4 phenotype.
Apo E is required for receptor-mediated clearance of chylomicron
and VLDL remnants from the circulation.
Impaired ApoE
clearance of
chylomicron
remnant and VLDL
Polygenic
Hypercholesterolemia
POLYGENIC HYPERCHOLESTEROLEMIA
ABOUT APO E
Ligand for hepatic chylomicron and VLDL remnant receptor, leading to
clearance of these lipoproteins from the circulation; ligand for LDL
receptor.
There are three different apo E alleles in humans:
E2, which has cysteine residues at positions 112 and 158
E3, which occurs in 60 to 80 percent of Caucasians and has cysteine at position 112 and
arginine at position 158
E4, which has arginine residues at positions 112 and 158.
Polygenic
Hypercholesterolemia
Familial / Monogenic
Hypertriglyceridaemia
Familial dysbeta-
Hyperlipidemia
lipoproteinemia
Familial combined
Monogenic
hyperlipedemia
Mixed
Hyperapobeta-
Polygenic
lipoproteinemia
FAMILIAL COMBINED HYPERLIPIDEMIA
FCHL is thought to be a genetically complex disease and the
phenotype is usually determined by interaction of multiple
susceptibility genes and the environment.
Co-inheritance of two or more gene variants potentially affecting
lipoprotein metabolism are generally required for the expression of
FCHL.
In an autosomal dominant pattern, an overproduction of hepatically-
derived apo B-100 is associated with very low density lipoprotein
(VLDL).
FAMILIAL COMBINED HYPERLIPIDEMIA
FCHL can be represented by one of three Fredrickson phenotypes
Combined elevations of triglycerides and cholesterol resulting from increases
in VLDL and LDL (type IIb)
Hypercholesterolemia due to an increase in LDL (type IIa)
Isolated hypertriglyceridemia induced by a rise in VLDL (type IV)
HYPERAPOBELATALIPOPROTEINEMIA
Hyperapobetalipoproteinemia is characterized by an overproduction
of apo B and may be a variant of familial combined hyperlipidemia.
This condition is characterized by LDL that are enriched in apo B-100.
It is manifested clinically by an elevation in the concentration of apo B,
but a normal concentration of LDL-cholesterol (LDL-C).
In most cases, the LDL-C level is less than 160 mg/dL (4.1 mmol/L), the
LDL apo B concentration is greater than 135 mg/dL (3.5 mmol/L), and
the LDL-to-apo B ratio is less than 1.2 (normal value >1.4)
Hypertriglyceridemia
Polygenic
Hypercholesterolemia
Familial / Monogenic
Acquired
Hereditary
Familial
Hypertriglyceridemia
Monogenic
Mixed
Polygenic
HYPERTRIGLYCERIDEMIA
The chylomicronemia syndrome is a disorder
characterized by severe hypertriglyceridemia
and massive accumulation of chylomicrons in
plasma.
Familial Combined
Hyperlipidemia
Hyperapobetaliproteinemia
Impaired LDL binding to LDLR
Increased plasma LDL
Familial
Hypercholesterolemia
LDLR defect
Dysfunctional PCSK9
Increased Apo B100
Secondary Causes: Hypertriglyceridemia
Endrocrine Disorders
Pregnancy and
Hormones
Acquired
Mixed Chylomicronemia
Hereditary
Familial
Hypertriglyceridemia
SECONDARY CAUSES: HYPERTRIGLYCERIDEMIA
ENDOCRINE: DIABETES
Insulin resistance
TG
HDL/ Cholesterol VLDL/
Phospholipids
LDL Estyl chylomicrons
NCBI
https://www.ncbi.nlm.nih.gov/pubmed/11905095